Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.42 +0.03 (+8.98%)
As of: Oct 21, 2026 · 3:59 PM EDT

Biodexa Pharmaceuticals (BDRX) Prepaid Assets (2018 - 2022)

Updated

Biodexa Pharmaceuticals (BDRX) reported Prepaid Assets of $441,021 for the quarter ended Dec 31, 2022, down 46.1% from $818,242 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Prepaid Assets (2018 - 2022) Analysis & Trends

As of Dec 31, 2022, Biodexa Pharmaceuticals posted Prepaid Assets of $465,341, down 44.3% from the prior year.

  • Prepaid Assets has a four-year compound annual growth rate of 25.8% (years ended Dec 2018 to Dec 2022).
  • By year, Prepaid Assets came in at $835,159 in the year ended Dec 31, 2021 (+152.1%), $331,310 in the year ended Dec 31, 2020 and $185,643 in the year ended Dec 31, 2018.
  • The figure for the quarter ended Dec 31, 2022 ranks as the lowest quarterly Prepaid Assets since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Biodexa Pharmaceuticals 4,123.69 -23.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 453,317.89
Dec 31, 2021 819,351.24
Dec 31, 2020 351,671.11
Jun 30, 2019 451,318.46
Dec 31, 2018 176,440.72
API Access

Biodexa Pharmaceuticals Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY